CN103357199B
(zh)
|
2003-12-30 |
2019-02-01 |
帝斯曼知识产权资产管理有限公司 |
脱气方法
|
BRPI0613358A8
(pt)
*
|
2005-07-08 |
2017-12-26 |
Dsm Ip Assets Bv |
ácidos de gordura poli - insaturada para o tratamento da demência e condições relacionadas à pré-demência
|
CA2692355C
(en)
*
|
2007-06-29 |
2018-09-11 |
Martek Biosciences Corporation |
Production and purification of esters of polyunsaturated fatty acids
|
EP3578177A1
(en)
|
2008-09-02 |
2019-12-11 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
|
JP5503856B2
(ja)
|
2008-09-10 |
2014-05-28 |
キユーピー株式会社 |
高度不飽和脂肪酸誘導体の取得方法
|
BRPI0924012A2
(pt)
|
2009-04-17 |
2019-09-24 |
Cela Vista Pharmaceuticals Ltd |
processo para obtenção de uma composição rica em ácidos graxos ômega 3 de um óleo de origem marinha, com um teor de af interior 90 mg/g composição, suplemento nutricional produto alimentar, composição farmacêutica, e, uso de um composto
|
RU2538691C2
(ru)
|
2009-04-29 |
2015-01-10 |
Амарин Фарма, Инк. |
Стабильные фармацевтические композиции и способы их применения
|
EP3563842A1
(en)
|
2009-04-29 |
2019-11-06 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
|
LT3318255T
(lt)
|
2009-06-15 |
2021-05-25 |
Amarin Pharmaceuticals Ireland Limited |
Kompozicijos ir būdai, skirti insulto gydymui pacientui kartu su statinų terapija
|
CA2775339C
(en)
|
2009-09-23 |
2017-03-28 |
Amarin Corporation Plc |
Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
|
EP2519332B1
(en)
*
|
2009-12-30 |
2014-03-05 |
BASF Pharma (Callanish) Limited |
Simulated moving bed chromatographic separation process for the purification of polyunsaturated fatty acids
|
US11712429B2
(en)
|
2010-11-29 |
2023-08-01 |
Amarin Pharmaceuticals Ireland Limited |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
NZ744990A
(en)
|
2010-11-29 |
2019-10-25 |
Amarin Pharmaceuticals Ie Ltd |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
GB201111595D0
(en)
|
2011-07-06 |
2011-08-24 |
Equateq Ltd |
Improved process
|
GB201111589D0
(en)
|
2011-07-06 |
2011-08-24 |
Equateq Ltd |
New modified process
|
GB201111591D0
(en)
|
2011-07-06 |
2011-08-24 |
Equateq Ltd |
Further new process
|
GB201111601D0
(en)
|
2011-07-06 |
2011-08-24 |
Equateq Ltd |
New process
|
GB201111594D0
(en)
|
2011-07-06 |
2011-08-24 |
Equateq Ltd |
New improved process
|
US11291643B2
(en)
|
2011-11-07 |
2022-04-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating hypertriglyceridemia
|
EP2775837A4
(en)
|
2011-11-07 |
2015-10-28 |
Amarin Pharmaceuticals Ie Ltd |
METHODS OF TREATING HYPERTRIGLYCERIDEMIA
|
EP2800469B1
(en)
|
2012-01-06 |
2021-08-25 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
|
EP4342546A3
(en)
|
2012-06-29 |
2024-05-22 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
|
US20150265566A1
(en)
|
2012-11-06 |
2015-09-24 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
|
US20140187633A1
(en)
|
2012-12-31 |
2014-07-03 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
|
US9814733B2
(en)
|
2012-12-31 |
2017-11-14 |
A,arin Pharmaceuticals Ireland Limited |
Compositions comprising EPA and obeticholic acid and methods of use thereof
|
GB201300354D0
(en)
|
2013-01-09 |
2013-02-20 |
Basf Pharma Callanish Ltd |
Multi-step separation process
|
US9452151B2
(en)
|
2013-02-06 |
2016-09-27 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing apolipoprotein C-III
|
US9624492B2
(en)
|
2013-02-13 |
2017-04-18 |
Amarin Pharmaceuticals Ireland Limited |
Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
|
US9662307B2
(en)
|
2013-02-19 |
2017-05-30 |
The Regents Of The University Of Colorado |
Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
|
US9283201B2
(en)
|
2013-03-14 |
2016-03-15 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for treating or preventing obesity in a subject in need thereof
|
US20140271841A1
(en)
|
2013-03-15 |
2014-09-18 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
|
US8802880B1
(en)
|
2013-05-07 |
2014-08-12 |
Group Novasep |
Chromatographic process for the production of highly purified polyunsaturated fatty acids
|
US9428711B2
(en)
|
2013-05-07 |
2016-08-30 |
Groupe Novasep |
Chromatographic process for the production of highly purified polyunsaturated fatty acids
|
US10966968B2
(en)
|
2013-06-06 |
2021-04-06 |
Amarin Pharmaceuticals Ireland Limited |
Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
|
US20150065572A1
(en)
|
2013-09-04 |
2015-03-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing prostate cancer
|
US9585859B2
(en)
|
2013-10-10 |
2017-03-07 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
|
CN103962091B
(zh)
*
|
2013-11-28 |
2017-01-25 |
大连工业大学 |
一种银离子改性氨基硅胶分离epa和dha的方法
|
EP2883860B1
(fr)
|
2013-12-11 |
2016-08-24 |
Novasep Process |
Procédé chromatographique de production d'acides gras polyinsaturés
|
WO2015104464A1
(fr)
|
2014-01-07 |
2015-07-16 |
Novasep Process |
Procédé de purification d'acides aminés aromatiques
|
US10561631B2
(en)
|
2014-06-11 |
2020-02-18 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing RLP-C
|
WO2015195662A1
(en)
|
2014-06-16 |
2015-12-23 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
|
US10406130B2
(en)
|
2016-03-15 |
2019-09-10 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
|
TW201900160A
(zh)
|
2017-05-19 |
2019-01-01 |
愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 |
用於降低腎功能下降之個體中的三酸甘油酯之組合物及方法
|
US11058661B2
(en)
|
2018-03-02 |
2021-07-13 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
|
FI4056176T3
(fi)
|
2018-09-24 |
2024-05-30 |
Amarin Pharmaceuticals Ie Ltd |
Menetelmät kardiovaskulaaristen tapahtumien riskin pienentämiseksi tutkittavassa
|
CN113574154A
(zh)
*
|
2019-03-26 |
2021-10-29 |
日清药业股份有限公司 |
含二十碳五烯酸烷基酯的组合物的制造方法
|
CN109912403A
(zh)
*
|
2019-04-18 |
2019-06-21 |
南京市第一医院 |
一种Omega-3制备大电导钙激活钾通道开放剂的方法
|
AU2022263358A1
(en)
|
2021-04-21 |
2023-11-30 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing the risk of heart failure
|